跳至主要内容
临床试验/CTRI/2020/02/023503
CTRI/2020/02/023503尚未招募3 期

Evaluation of Dual dye technique for sentinel lymph node biopsy in breast cancer: Two arm open label parallel design Non-inferiority Randomized controlled trial

All India Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Upfront operable primary breast tumor measuring upto and including 5cm in maximum tumor dimension with clinically lymph node negative breast cancers (Tis, T1,T2-N0)
  • 2. Consenting patient

排除标准

  • 1.With T3, T4 lesions
  • 2.Who are Pregnant, Lactating
  • 3.Patients with history of previous radiotherapy to the breast or axilla
  • 4.Patients with history of previous surgery of Axilla or chest wall
  • 5.Patients who have received Neo-adjuvant chemotherapy
  • 6.H/o hypersensitivity to any of the agents used
  • 7.Not giving consent

研究者

相似试验